Hey, it's Kramer, and this is my morning take on the market from today's

CBC Investing Club morning meeting.

Just talking about dividends, we added a pretty big yield stock to the portfolio today.

Bristol Myers yields about 4%, but that's not exactly why we're buying it.

There's many other reasons.

The key being, yes, they have this patent cliff coming, talking about trough earnings in 2028 as, you know, as they lose key drugs, you know, the patent protection.

But they have this schizophrenia drug.

First approved.

First drug approved by the FDA in over 30 years.

Let's go over that because it's really important.

This was a very seminal breakthrough by Bristol Myers.

They bought a company, good career.

Caruna therapeutics.

And there is nothing for people of schizophrenia.

Now, schizophrenia is one of the diseases.

People say, who are those unfortunate people who are homeless

or they've not been able to keep a job? Well, it tends to be a preponderance of them have

some degree of schizophrenia. And it also may work for bipolar. The tragedy of this, by the way,

is that the drugs, they all created a use weight gain. So then people got very sensitive to it and got off the drugs. People are always getting off the drug. This one has no side effects that we've seen. So therefore, I think, and I know I'm putting out a bold target there, this could be $20 billion. Okay, so JP Morgan, they think $5 billion by 2030, but they think it could go in the $10 billion range if it gets approved for additional indication. Well, we just saw how hard on this, Abvi just tried to do it? Abbey's a great company. They couldn't do it. And that sent the stock there. Right. And then I want to wait. I do want to wait until it goes lower because of the patent cliff, which was reflected here. But I think Chris

Berners doing a remarkable job running the company. And I think people don't understand that this

is an inexpensive stock. It's very inexpensive. Eight times earnings. Yeah, not expensive at all.

We also added to Eli Lilly, finally not restricted. Remember last Monday we wanted to buy

...